News & stories – CEPI

Latest news

Filter by category:

FILTER: ALL CATEGORIESFilter by:

Latest news

Inspiring the next generation of women scientists

For International Women's Day, CEPI’s women scientists explore what changes are needed to inspire more girls and women to pursue a career in science

The barriers to success as a woman in science

On International Women's Day, CEPI's women scientists share their quick-fire tips for overcoming these barriers

How to succeed as a woman in science

In the run-up to International Women's Day, CEPI’s women scientists share their experiences, from the best and worst career advice to the most influential role models

CEPI and partners collaborate to advance key tools for Sudan ebolavirus vaccine research

International antibody standard will standardize assessment of vaccines against SUDV, contributing to eventual licensure.

#AskWomenInScience: CEPI’s world-class team of women scientists answer your questions

#AskWomenInScience aims to spotlight the crucial role of women in science, support aspiring girl and women scientists and advocate for greater gender equality

Stabilised mRNA vaccine technology aims to end need for frozen storage and improve access

CEPI to initially provide up to USD850,000 to 20Med to advance development of 20Med’s bioresponsive polymeric nanoparticle platform for mRNA stabilisation and delivery.

New book challenges world leaders to get behind 100 Days Mission to end pandemics

A must-read inside track on how the world can stop future pandemics

CEPI and Institut Pasteur de Dakar announce 10-year partnership to boost manufacturing of affordable vaccines for the Global South

CEPI will invest up to $50m in partnership to advance equitable access to routine and outbreak vaccines in Africa

Coming in from the cold: needle-free patch technology for mRNA vaccines aims to end need for frozen storage and improve access

CEPI to provide up to USD4.3 million (AUD6.4 million) to Vaxxas to advance development of its high-density microarray patch for mRNA vaccines.

Real-world effectiveness of COVID-19 vaccines

Real-world vaccine-effectiveness data are essential to inform vaccine roll-out strategies, especially in resource-limited countries. But for some COVID-19 vaccines, such data are limited.

CEPI, Belgian universities to partner to enhance global pandemic preparedness

Organisations intend to collaborate in areas that will contribute to improved global pandemic preparedness, in particular with respect to KU Leuven’s VirusBank Platform and the University of Antwerp’s Vaccinopolis facility.

Twitter

Follow

Tweets by CEPIvaccines

Media enquiries

Get involved in our cause

Become a partner